The Global Recombinant DNA Technology Market will grow considerably in the coming years due to exceptional scientific advancements in gene therapy. According to a report by Fortune Business Insights, titled “Recombinant DNA Technology Market Size, Share and Global Trend By Product (Vaccines, Therapeutic Agents, Recombinant Protein, Others), By Component (Vectors, Expression System, Others), By Application (Diagnostics, Therapeutics, Food and Agriculture, Others), By End User (Biotechnology and Pharmaceutical Companies, Diagnostic Laboratories, Academic and Government Research Institutes, Other) and Geography Forecast till 2026,” the market will derive growth from the growing emphasis on research and development of recombinant DNA.
Some of the Main Key Players Covered in the Report
- Novartis AG
- Thermo Fisher Scientific Inc.
- Sanofi Pasteur Limited
- Merck KGaA, Genentech Inc.
- GlaxoSmithKline plc.
- Eli Lilly and Company
- Pfizer Inc.
- Janssen Pharmaceuticals Inc.
North America to Emerge as Leading Region; Strategic Collaborations are Key Growth Drivers
The report provides segmentation of the global recombinant NA technology market based on several aspects such as product, component type, application, end users, and regional demographics. Based on regional demographics, the report highlights some of the leading regions that have made their name heard in the global recombinant DNA technology market in recent years. Among all regions, Fortune Business Insights expects North America to emerge dominant in the coming years.
Growing investment in research and development of recombinant DNA technology, combined with increasing number of company collaborations will aid the growth of the recombinant DNA technology market in the coming years.
The recombinant DNA technology involves the process of combining molecules of two different species that are used to produce a new genetic combination. The applications of recombinant DNA technology across diversified domains have led to an increased global adoption across the world.
Key Segmentation of Recombinant DNA Technology Market:
- By Product
- Therapeutic Agents
- Recombinant Protein
- By Component
- Expression System
- By Application
- Food and Agriculture
- By End User
- Biotechnology and Pharmaceutical Companies
- Diagnostic Laboratories
- Academic and Government Research Institutes
- By Geography
- North America (U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, and Rest of Latin America)
- Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)
In addition to widespread applications, recent scientific advancements have contributed to the growing demand for recombinant DNA technology across the world. Backed by exceptional product advancements, recombinant DNA technology established dominance in the field of medicine and healthcare. The ability to develop radioactive probes has aided the recombinant DNA industry, owing to its ability to diagnose several diseases.
More Trending Topics from Fortune Business Insights:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.